Approved Symbol |
Approved Name |
Location |
Source |
PLA2G2A |
phospholipase A2, group IIA (platelets, synovial fluid) |
1p35 |
Mapped by PBA pathway |
PLA2G1B |
phospholipase A2, group IB (pancreas) |
12q23-qter |
Mapped by PBA pathway |
PLA2G2E |
phospholipase A2, group IIE |
1p36.13 |
Mapped by PBA pathway |
PLA2G2D |
phospholipase A2, group IID |
1p36.12 |
Mapped by PBA pathway |
PEMT |
phosphatidylethanolamine N-methyltransferase |
17p11.2 |
Mapped by significant region |
PLA2G4B |
phospholipase A2, group IVB (cytosolic) |
15q11.2-q21.3 |
Mapped by PBA pathway |
PLA2G3 |
phospholipase A2, group III |
22q12.2 |
Mapped by PBA pathway |
PLA2G5 |
phospholipase A2, group V |
1p36-p34 |
Mapped by PBA pathway |
LPCAT1 |
lysophosphatidylcholine acyltransferase 1 |
5p15.33 |
Mapped by LD-proxy |
PLA2G10 |
phospholipase A2, group X |
16p13.1-p12 |
Mapped by PBA pathway; Mapped by significant region |
PLA2G6 |
phospholipase A2, group VI (cytosolic, calcium-independent) |
22q13.1 |
Mapped by PBA pathway |
MBOAT1 |
membrane bound O-acyltransferase domain containing 1 |
6p22.3 |
Mapped by LD-proxy; Mapped by literature SNP |
ACHE |
acetylcholinesterase |
7q22 |
Mapped by PBA pathway |
PLD1 |
phospholipase D1, phosphatidylcholine-specific |
3q26 |
Mapped by PBA pathway |
MBOAT2 |
membrane bound O-acyltransferase domain containing 2 |
2p25 |
Mapped by significant region |
GPAT2 |
glycerol-3-phosphate acyltransferase 2, mitochondrial |
2q11.2 |
Mapped by LD-proxy |
CHKA |
choline kinase alpha |
11q13.1 |
Mapped by significant region |
PLD2 |
phospholipase D2 |
17p13.3 |
Mapped by PBA pathway |
LYPLA1 |
lysophospholipase I |
8q11.23-q12.1 |
Mapped by PBA pathway |
LPCAT4 |
lysophosphatidylcholine acyltransferase 4 |
15q14 |
Mapped by CNV |
CDIPT |
CDP-diacylglycerol--inositol 3-phosphatidyltransferase |
16p12.1 |
Mapped by CNV |